TOWA Corporation provided consolidated earnings guidance for the year ending March 31, 2023. For the year, the company expects net sales of ¥55,000 million, operating profit of ¥12,200 million and profit attributable to owners of parent of ¥8,500 million or ¥339.88 basic earnings per share.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
13,380 JPY | +1.52% | +20.22% | +87.66% |
Mar. 25 | Towa Pharmaceutical Completes Payment for Director Stock Compensation | MT |
Feb. 07 | Towa Corporation Provides Dividend Guidance for the Year Ending March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+87.66% | 2.15B | |
+30.86% | 176B | |
+38.27% | 34.77B | |
-10.97% | 29.86B | |
+18.43% | 21.39B | |
-0.95% | 11.32B | |
-14.90% | 11.22B | |
+126.74% | 9.97B | |
+25.61% | 5.77B | |
-24.31% | 4.77B |
- Stock Market
- Equities
- 6315 Stock
- News TOWA Corporation
- TOWA Corporation Provides Consolidated Earnings Guidance for the Year Ending March 31, 2023